Evenity Injection, Solution
Product Images NDC 55513-509

12 FDA label images from Amgen, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Evenity (NDC 55513-509). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Evenity 01)

Figure A (Evenity 01)
An instructional diagram illustrating a syringe labeled with components including a gray needle cap, syringe barrel containing medicine, label and expiration date on the barrel, finger flange, and plunger rod, showing an injection device assembly.*
FDA Label Image

Figure B (Evenity 02)

Figure B (Evenity 02)
An illustration showing recommended injection sites for a subcutaneous injection of Evenity (romosozumab-aqqg). The diagram highlights the upper arm, abdomen, and thigh areas on a human figure as suitable sites for administration.*
FDA Label Image

Figure C (Evenity 03)

Figure C (Evenity 03)
An instructional diagram showing two hands demonstrating a medical injection preparation technique. The top hand holds a vial inverted with an arrow indicating upward motion; the bottom hand holds a syringe drawing liquid from the vial, labeled as Figure C.*
FDA Label Image

Figure D (Evenity 04)

Figure D (Evenity 04)
Instructional illustration showing a hand administering a subcutaneous injection with a syringe or pen into the skin, demonstrating the proper injection technique. Labeled as Figure D.*
FDA Label Image

Figure E (Evenity 05)

Figure E (Evenity 05)
An instructional diagram showing the use of a subcutaneous injection device, likely for Evenity (romosozumab-aqqg). The two-panel illustration depicts hands administering the injection into the skin, highlighting the pressing and release motions on the device for proper use.*
FDA Label Image

Figure A (Evenity 06)

Figure A (Evenity 06)
Evenity 105 mg/1.17 mL injection solution label for subcutaneous use by Amgen, Inc. The label shows two single-use prefilled syringes each containing 105 mg/1.17 mL for a total dose of 210 mg/2.34 mL. It includes storage instructions, warnings, and visual dosage representation. The label is marked for healthcare provider use only.*
FDA Label Image

Figure B (Evenity 07)

Figure B (Evenity 07)
An anatomical illustration showing recommended subcutaneous injection sites on a human body. Highlighted areas include the upper arm, abdomen, and thigh, each labeled accordingly. The diagram supports proper injection location guidance for subcutaneous drug administration.*
FDA Label Image

Figure C (Evenity 08)

Figure C (Evenity 08)
Instructional illustration showing a hand removing the cap from a syringe, with an arrow indicating the direction to pull, followed by a hand holding the syringe ready for use. The image demonstrates proper preparation of an injection device.*
FDA Label Image

Figure D (Evenity 09)

Figure D (Evenity 09)
An instructional diagram showing a person administering a subcutaneous injection using a syringe at a 45-degree angle into the skin. The illustration highlights proper hand positioning and needle angle for injection.*
FDA Label Image

2 X 105 mg/1.17 mL Single-use Prefilled Syringe Ndc 55513-880-02 Evenity® (romosozumab-aqqg) Injection For Healthcare Provider Use Only 105 mg/1.17 mL + 105 mg/1.17 mL = 1 Dose 210 mg/2.34 mL 2 X 105 mg/1.17 mL 105 mg/1.17 mL For Subcutaneous Use Only Sterile Solution – No Preservative Store Refrigerated At 2°c To 8°c (36°f To 46°f). Do Not Freeze Or Shake. Store In Carton To Protect From Light. Keep Out Of The Sight And Reach Of Children. Attention: Provide The Enclosed Medication Guide To Each Patient. For More Copies See Evenity.com Or Call 1-800-77amgen. 2 Syringes Must Be Administered For A Full 210 mg/2.34 mL Dose Rx Only Amgen® Ucb (Evenity 10)

2 X 105 mg/1.17 mL Single-use Prefilled Syringe Ndc 55513-880-02 Evenity® (romosozumab-aqqg) Injection For Healthcare Provider Use Only 105 mg/1.17 mL + 105 mg/1.17 mL = 1 Dose 210 mg/2.34 mL 2 X 105 mg/1.17 mL 105 mg/1.17 mL For Subcutaneous Use Only Sterile Solution – No Preservative Store Refrigerated At 2°c To 8°c (36°f To 46°f). Do Not Freeze Or Shake. Store In Carton To Protect From Light. Keep Out Of The Sight And Reach Of Children. Attention: Provide The Enclosed Medication Guide To Each Patient. For More Copies See Evenity.com Or Call 1-800-77amgen. 2 Syringes Must Be Administered For A Full 210 mg/2.34 mL Dose Rx Only Amgen® Ucb (Evenity 10)
Evenity (romosozumab-aqqg) injection 105 mg/1.17 mL carton label for subcutaneous injection by Amgen, Inc. The packaging contains 2 single-use prefilled syringes, each with 105 mg/1.17 mL solution, totaling a 210 mg/2.34 mL dose. The label includes storage instructions, dosage form, and a dosing diagram showing two syringes combined for one full dose.*
FDA Label Image

Principal Display Panel (105 mg/1.17 mL Syringe Carton)

Principal Display Panel (105 mg/1.17 mL Syringe Carton)
Evenity (romosozumab-aqqg) injection 105 mg/1.17 mL is a sterile solution for subcutaneous use supplied in single-use prefilled syringes. The package contains 2 syringes, each with 105 mg/1.17 mL, which together provide one dose of 210 mg/2.34 mL. The label indicates storage refrigerated at 2°C to 8°C (36°F to 46°F) and highlights no preservatives in the solution. The product is labeled for healthcare provider use only and is manufactured by Amgen, Inc.*
FDA Label Image

Principal Display Panel (105 mg/1.17 mL Syringe Carton)

Principal Display Panel (105 mg/1.17 mL Syringe Carton)
Evenity (romosozumab-aqqg) injection 105 mg/1.17 mL by Amgen, Inc. This label shows packaging for 2 single-use prefilled syringes, each containing 105 mg/1.17 mL for subcutaneous use. Two syringes must be administered for a full 210 mg/2.34 mL dose. The product is a sterile solution with no preservative, indicated for healthcare provider use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.